Papers

Peer-reviewed Lead author Corresponding author International journal
Jun 1, 2018

Aquaporin Positron Emission Tomography Differentiates Between Grade III and IV Human Astrocytoma

Neurosurgery
  • Yuji Suzuki
  • Yukihiro Nakamura
  • Kenichi Yamada
  • Satoshi Kurabe
  • Kouichirou Okamoto
  • Hiroshi Aoki
  • Hiroki Kitaura
  • Akiyoshi Kakita
  • Yukihiko Fujii
  • Vincent J Huber
  • Hironaka Igarashi
  • Ingrid L Kwee
  • Tsutomu Nakada
  • Display all

Volume
82
Number
6
First page
842
Last page
846
Language
English
Publishing type
Research paper (scientific journal)
DOI
10.1093/neuros/nyx314
Publisher
Oxford University Press (OUP)

<title>Abstract</title>
<sec>
<title>BACKGROUND</title>
Aquaporin (AQP) water channels play a significant role in mesenchymal microvascular proliferation and infiltrative growth. AQPs are highly expressed in malignant astrocytomas, and a positive correlation is observed between their expression levels and histological tumor grade.


</sec>
<sec>
<title>OBJECTIVE</title>
To examine the utility of aquaporin positron emission tomography (PET) for differentiating between astrocytoma grade III and grade IV using the AQP radioligand [11C]TGN-020.


</sec>
<sec>
<title>METHODS</title>
Fifteen astrocytoma patients, grade III (n = 7) and grade IV (n = 8), and 10 healthy volunteers underwent [11C]TGN-020 aquaporin PET imaging. Surgical tissues of astrocytoma patients were examined for histopathological grading using the WHO classification standard and expression of AQP1 and AQP4 immunohistochemically.


</sec>
<sec>
<title>RESULTS</title>
Mean standardized uptake values of astrocytoma grade III and IV (0.51 ± 0.11 vs 1.50 ± 0.44, respectively) were higher than normal white matter (0.17 ± 0.02, P &amp;lt; .001) for both tumor grades. Importantly, mean standardized uptake values of astrocytoma grade IV were significantly higher than grade III (P &amp;lt; .01).


</sec>
<sec>
<title>CONCLUSION</title>
Our study demonstrated that [11C]TGN-020 aquaporin PET imaging differentiated between astrocytoma grades III and IV. We suggest its clinical application as a noninvasive diagnostic tool would lead to advancements in the management of these malignant brain tumors.


</sec>

Link information
DOI
https://doi.org/10.1093/neuros/nyx314
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/28645205
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952963
URL
http://academic.oup.com/neurosurgery/article-pdf/82/6/842/32599822/nyx314.pdf
ID information
  • DOI : 10.1093/neuros/nyx314
  • ISSN : 0148-396X
  • eISSN : 1524-4040
  • Pubmed ID : 28645205
  • Pubmed Central ID : PMC5952963

Export
BibTeX RIS